What is the appropriate starting nightly dose of Basaglar (insulin glargine) for a patient with an A1c of 9.2%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Starting Dose of Basaglar for A1c 9.2%

Start Basaglar at 10 units once daily OR 0.1-0.2 units/kg once daily, administered at the same time each evening. 1, 2

Dosing Algorithm

The 2025 ADA Standards of Care provide clear guidance for basal insulin initiation that applies directly to Basaglar (insulin glargine):

  • Fixed dose approach: Start with 10 units subcutaneously once daily
  • Weight-based approach: Start with 0.1-0.2 units/kg once daily
  • Choose whichever method you prefer - both are equally endorsed 1

The FDA label for Basaglar specifically states for type 2 diabetes: "0.2 units/kg or up to 10 units once daily" 2. This aligns perfectly with the ADA guidelines.

Why This Dose for A1c 9.2%

With an A1c of 9.2%, this patient has significant hyperglycemia but does not meet criteria for more aggressive insulin initiation. The ADA notes that A1c >10% or blood glucose ≥300 mg/dL warrants consideration of higher starting doses or combination therapy 1. At 9.2%, the standard conservative starting dose is appropriate and safe.

Titration Strategy

After initiating at 10 units (or 0.1-0.2 units/kg):

  • Set a fasting plasma glucose (FPG) goal - typically 80-130 mg/dL
  • Increase by 2 units every 3 days until FPG reaches goal without hypoglycemia 1
  • Monitor closely - check FPG daily during titration
  • If hypoglycemia occurs: Determine cause; if no clear reason, reduce dose by 10-20% 1

Administration Details

  • Timing: Once daily at the same time every day (bedtime is traditional but any consistent time works) 2
  • Injection sites: Rotate between abdomen, thigh, or deltoid 2
  • Do not mix with other insulins or solutions 2

Common Pitfalls to Avoid

Underdosing at initiation: Some clinicians start too conservatively. The 10 unit or 0.1-0.2 units/kg starting dose is already conservative and evidence-based. Research shows that adequate starting doses (around 0.15 units/kg) lead to better A1c reduction 3, 4.

Inadequate titration: The most critical error is failing to titrate aggressively enough. Increase by 2 units every 3 days consistently until FPG is at goal 1. Don't wait weeks between adjustments.

Overbasalization: Eventually (usually around 0.5-1.0 units/kg/day), if FPG remains elevated despite dose increases, consider adding prandial insulin or intensifying other therapies rather than continuing to escalate basal insulin indefinitely 1, 5.

Expected Outcomes

With proper titration, patients starting at A1c 9.2% typically achieve:

  • A1c reduction of 1.5-2.5% over 24 weeks 4, 6
  • FPG target of <110-130 mg/dL 4
  • Final basal insulin dose often ranges from 0.3-0.5 units/kg/day for most patients with type 2 diabetes 5, 7

Adjunctive Therapy Considerations

Continue metformin if the patient is already taking it - proven mortality benefit 7. Consider whether GLP-1 receptor agonists or SGLT2 inhibitors should be added or prioritized instead of insulin, particularly if cardiovascular disease, heart failure, or chronic kidney disease are present 1.

Related Questions

Can I decrease my Lantus (insulin glargine) dose by 10 units?
What basal insulin glargine (Lantus) dose should be used for a patient receiving about 220 g/day of tube‑feed carbohydrates, currently on 68 units daily, with prednisone being tapered from 45 mg to 40 mg?
In a 47-year-old male with uncontrolled diabetes (glucose 369 mg/dL) who has been off medication for over a year, can I initiate basal insulin with insulin glargine (Lantus) now?
What should the basal insulin glargine (Lantus) dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be for a 35‑year‑old male, 80 kg, with serum creatinine 1.18 mg/dL (eGFR 87 mL/min/1.73 m²), fasting blood glucose 73 mg/dL while on 32 U nightly Lantus, and current ISF 25 mg/dL per unit and ICR 10 g per unit?
For a 25‑year‑old woman at 28 weeks gestation with type 2 diabetes, weight 114 kg, on insulin glargine (Lantus) 32 U daily, insulin‑to‑carbohydrate ratio 1 U:5 g, and insulin sensitivity factor 1 U:25 mg/dL, who ate 55 g carbohydrate at 6 pm and had blood glucose 183 mg/dL at 9 pm and fasting glucose 187 mg/dL, how should her insulin sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted?
Is it safe to continue hydrochlorothiazide (a thiazide diuretic) in a patient with an estimated glomerular filtration rate of 48 mL/min/1.73 m²?
What intravenous fluid is best for hydrating a pregnant patient with oligohydramnios?
What level of pregnancy‑associated plasma protein‑A (PAPP‑A) is considered low?
When should N‑acetylcysteine (acetylcysteine) be administered in acute hepatitis?
For a patient with type 2 diabetes who cannot tolerate sodium‑glucose cotransporter‑2 inhibitors, glucagon‑like peptide‑1 receptor agonists, or metformin, refuses insulin, and has a hemoglobin A1c of 7.7%, what oral therapy should be prescribed?
When is it appropriate to give a wheezing patient 500 ml of normal saline intravenously?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.